Literature DB >> 11304828

Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder.

W J Muir1, M L Thomson, P McKeon, L Mynett-Johnson, C Whitton, K L Evans, D J Porteous, D H Blackwood.   

Abstract

Following the description of linkage of markers at chromosome 4p16 to bipolar disorder in several families [Blackwood et al., 1996], and the association of the alleles of a polymorphism closely linked to D5 dopamine receptor gene with schizophrenia [Williams et al., 1997], we have looked for linkage disequilibrium between a series of microsatellite markers from this region and major psychoses including schizophrenia, bipolar disorder, and unipolar major depressive disorder. A significant increase in the frequency of the 148 bp allele of DRD5 (P = 0.024) and the 244 bp allele of D4S615 (P = 0.001) was found in patients with schizophrenia (n = 158 DRD5; n = 133 D4S615), compared with patients with bipolar disorder (n = 270 DRD5; n = 107 D4S615), or controls without psychiatric illness (n = 437 DRD5; n = 309 D4S615). The frequency of the 148 bp allele of DRD5 was also increased in schizophrenia over unipolar major depressive disorder (n = 65). D4S615 was not typed in unipolar disorder. The estimated odds ratios confirmed that the 148 bp allele of DRD5 and the 244 bp allele of D4S615 conferred increased risk of schizophrenia. Estimated Haplotype (EH) analysis of 174 controls and 128 patients with schizophrenia who were typed for both markers confirmed the strong associations with these alleles but did not show evidence that the markers were in linkage disequilibrium with each other even though they lie approximately 150 kb apart. The data are consistent with an association between markers close to the D5 dopamine receptor and schizophrenia, but not bipolar disorder or unipolar major depression. Copyright 2001 Wiley-Liss. Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304828     DOI: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1163>3.0.co;2-2

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  Molecular genetics of schizophrenia: a critical review.

Authors:  Neeraj Berry; Vaidehi Jobanputra; Hemraj Pal
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

Review 2.  Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.

Authors:  Zuowei Wang; David E Kemp; Philip K Chan; Yiru Fang; Stephen J Ganocy; Joseph R Calabrese; Keming Gao
Journal:  Int J Neuropsychopharmacol       Date:  2010-09-29       Impact factor: 5.176

Review 3.  From dopaminergic genes to psychiatric disorders.

Authors:  Janet Hoenicka; María Aragüés; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel A Jiménez-Arriero; Tomás Palomo
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

4.  [In memory of Lev L'vovich Kiselev].

Authors:  A A Bogdanov; V G Debabov
Journal:  Mol Biol (Mosk)       Date:  2008 Sep-Oct

5.  Dopamine reduction of GABA currents in striatal medium-sized spiny neurons is mediated principally by the D(1) receptor subtype.

Authors:  Elizabeth Hernández-Echeagaray; Carlos Cepeda; Marjorie A Ariano; Mary Kay Lobo; David R Sibley; Michael S Levine
Journal:  Neurochem Res       Date:  2006-09-22       Impact factor: 3.996

6.  SNP discovery and haplotype analysis in the segmentally duplicated DRD5 coding region.

Authors:  Donna J E Housley; Molly Nikolas; Patrick J Venta; Kathrine A Jernigan; Irwin D Waldman; Joel T Nigg; Karen H Friderici
Journal:  Ann Hum Genet       Date:  2009-03-30       Impact factor: 1.670

Review 7.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

8.  The dopamine receptor D5 gene shows signs of independent erosion in toothed and baleen whales.

Authors:  Luís Q Alves; Juliana Alves; Rodrigo Ribeiro; Raquel Ruivo; Filipe Castro
Journal:  PeerJ       Date:  2019-10-11       Impact factor: 2.984

Review 9.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.